# Wells A. Messersmith

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wells-a-messersmith/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,971 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 71 |
| i10-index | 219 |
| Last Known Institution | University of Colorado Cancer Center |
| OpenAlex ID | https://openalex.org/A5078259926 |
| ORCID iD | https://orcid.org/0000-0003-2349-0885 |
| Works | 784 |

## Researcher papers

- [Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/colon-cancer-version-2-2021-nccn-clinical-practice-guidelines-in-oncology/)
- [Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/rectal-cancer-version-2-2022-nccn-clinical-practice-guidelines-in-oncology/)
- [Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial](https://scholariq.org/papers/safety-pharmacokinetic-pharmacodynamic-and-efficacy-data-for-the-oral-mek/)
- [Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial](https://scholariq.org/papers/activity-of-the-oral-mek-inhibitor-trametinib-in-patients-with-advanced-melanoma/)
- [NCCN Guidelines Insights: Rectal Cancer, Version 6.2020](https://scholariq.org/papers/nccn-guidelines-insights-rectal-cancer-version-6-2020/)
- [Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors](https://scholariq.org/papers/phase-i-study-of-ro4929097-a-gamma-secretase-inhibitor-of-notch-signaling-in/)
- [Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer](https://scholariq.org/papers/comprehensive-genomic-landscapes-in-early-and-later-onset-colorectal-cancer/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [University of Colorado Cancer Center](https://scholariq.org/institutions/university-of-colorado-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.